Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®.

Nagaendran, Kandiah,; Paulus Anam, Ong,; Turana, Yuda,; Li-Ling, Ng,; Kaysar, Mamun,; Reshma Aziz, Merchant,; Christopher, Chen,; Jacqueline, Dominguez,; Simeon, Marasigan,; Encarnita, Ampil,; Van Thong, Nguyen,; Suraya, Yusoff,; Yee Fai, Chan,; Fee Mann, Yong,; Orapitchaya, Krairit,; Chuthamanee, Suthisisang,; Vorapun, Senanarong,; Yong, Ji,; Ramesh, Thukral,; Ralf, Ihl,

doi:10.1111/cns.13095

Public

Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®.

Published in CNS neuroscience & therapeutics • Feb 1, 2019

Authors:

Kandiah, Nagaendran

Ong, Paulus Anam

Yuda, Turana

Abstract

BACKGROUND: The Ginkgo biloba special extract, EGb 761® has been widely used in the treatment of neuropsychiatric disorders, including Alzheimer's disease (AD). METHODS: To guide clinical practice in the Asian region, the Asian Clinical Expert Group on Neurocognitive Disorders compiled evidence-base...

Subject

Ginkgo biloba

Alzheimer disease

EGb 761®

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!